Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Haploidentical Stem Cell Transplantation Attenuates the Prognostic Impact of FLT3-ITD in Acute Myeloid Leukemia

Jonathan Canaani, MD, Myriam Labopin, MD, Xiao Jun Huang, William Arcese, MD, Fabio Ciceri, MD, Didier Blaise, MD PhD, Giuseppe Irrera, Lucia Lopez Corral, Benedetto Bruno, MD PhD, Stella Santarone, MD, Maria Teresa van Lint, Antonin Vitek, MDPhD, Jordi Esteve, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2017) 130 (Supplement 1): 4584.

https://doi.org/10.1182/blood.V130.Suppl_1.4584.4584

Published: 2017

Journal Articles

Use of Bone Marrow or Peripheral Blood Stem Cell Grafts in Non T Cell Depleted Haploidentical Transplants Using Post-Transplant Cyclophosphamide, an ALWP-EBMT Analysis

Annalisa Ruggeri, MD, Myriam Labopin, MD, Andrea Bacigalupo, MD, Zafer Gülbas, MD, Yener Koc, MD, Didier Blaise, MD PhD, Benedetto Bruno, MD PhD, Giuseppe Irrera, MD, Johanna Tischer, Jean diez Martin, Luca Castagna, MD, Fabio Ciceri, MD, Mohamad Mohty, MD PhD, Arnon Nagler

Blood (2016) 128 (22): 1165.

https://doi.org/10.1182/blood.V128.22.1165.1165

Published: 2016

Journal Articles

Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF

Massimo Martino, MD, Mercedes Gori, Annalisa Pitino, Antonella Dattola, Roberta Fedele, MD, Giuseppe Alberto Gallo, Santina Barillà, Antonella Pontari, Giuseppe Irrera, MD, Giuseppe Messina, MD, Tiziana Moscato, Giuseppe Console, MD, Fortunato Morabito, Giovanni Tripepi

Blood (2016) 128 (22): 3380.

https://doi.org/10.1182/blood.V128.22.3380.3380

Published: 2016

Journal Articles

Fast and Non-Invasive Identification of Tumorigenic-Proliferative Biomarker in Myeloproliferative and Lymphoproliferative Disorders

Iolanda Donatella Vincelli, Bruno Martino, MD, Maria Cuzzola, Giuseppe Irrera, Patrizia Cufari, Massimo Martino, Massimo Gentile, Stefania Ciolli, AnnaMaria Zaccuri, Daniela Pontoriero, Carmela Rigolino, Angela Violi, Francesca Ronco

Blood (2015) 126 (23): 5305.

https://doi.org/10.1182/blood.V126.23.5305.5305

Published: 2015

Journal Articles

A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy

Massimo Martino, MD, Messina Giuseppe, MD, Roberta Fedele, MD, Giuseppe Irrera, MD, Console Giuseppe, MD, Giuseppe Alberto Gallo, Iolanda Donatella Vincelli, Francesca Ronco, Massimo Gentile, MD, Fortunato Morabito, MD

Blood (2015) 126 (23): 3197.

https://doi.org/10.1182/blood.V126.23.3197.3197

Published: 2015

Journal Articles

Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience

Massimo Martino, MD, Giuseppe Messina, MD, Tiziana Moscato, MD, Roberta Fedele, MD, Giuseppe Console, MD, Giuseppe Console, MD, Iolanda Donatella Vincelli, MD, Francesca Ronco, MD, Giuseppe Irrera, MD

Blood (2014) 124 (21): 2516.

https://doi.org/10.1182/blood.V124.21.2516.2516

Published: 2014

Journal Articles

Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting

Massimo Martino, MD, Tiziana Moscato, MD, Iolanda Donatella Vincelli, MD, Francesca Ronco, Roberta Fedele, MD, Giuseppe Irrera, MD, Giuseppe Console, MD, Giuseppe Messina, MD, Eugenio Piro, MD, Stefano Molica, MD, Fortunato Morabito, MD

Blood (2014) 124 (21): 5825.

https://doi.org/10.1182/blood.V124.21.5825.5825

Published: 2014

Journal Articles

Validation of the Cibmtr Score in Predicting the Outcome of Hematopoietic Stem-Cell Transplantation in AML Patients Not in Complete Remission At the Time of Conditioning: A Retrospective Analysis On Behalf of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Blood (2012) 120 (21): 2005.

https://doi.org/10.1182/blood.V120.21.2005.2005

Published: 2012

Journal Articles

Autologous Hematopotoietic Stem Cell Transplantation in Multiple Sclerosis with An Intermediate Intensity Conditioning Regimen: The Italian Multi-Centre Experience

Blood (2011) 118 (21): 334.

https://doi.org/10.1182/blood.V118.21.334.334

Published: 2011

Journal Articles

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

Massimo Martino, MD, Grazia Pellicano’, MD, Tiziana Moscato, MD, Elisabetta Massara, MD, Roberta Fedele, MD, Giuseppe Console, MD, Letteria Russo, Miss, Giuseppe Messina, MD, Rosalba Di Filippo Scali, Giuseppe Irrera, MD

Blood (2011) 118 (21): 4497.

https://doi.org/10.1182/blood.V118.21.4497.4497

Published: 2011

Journal Articles

Is Antifungal Prophylaxis Useful In Stem Cell Transplantation (SCT) During Hospitalization?.

Giuseppe Irrera, MD, Messina Giuseppe, MD, Giuseppe Console, MD, Massimo Martino, MD, Cuzzola Maria, Antonella Meliadò, Pasquale Iacopino

Blood (2010) 116 (21): 4541.

https://doi.org/10.1182/blood.V116.21.4541.4541

Published: 2010

Journal Articles

Incidence of Febrile Episode During Stem Cell Mobilization (SCM) After High Dose Ciclophosphamide Chemotherapy (HD-CTX) and G-CSF (filgrastim or lenograstim) Administration in Multiple Myeloma (MM) Patients: II Interim Evaluation

Enrico Orciuolo, Gabriele Buda, E. Mauro, E. Marturano, Domenico Pastore, Paola Della Cioppa, Giuseppe Pietrantuono, Letizia Lombardini, Nicola Di Renzo, MD, Giuseppe Irrera, MD, Clotilde Cangialosi, Marino Brunori, Mario Petrini, MD

Blood (2008) 112 (11): 4135.

https://doi.org/10.1182/blood.V112.11.4135.4135

Published: 2008

Journal Articles

Autologous Stem Cell Transplantation (ASCT) with Busulfan Plus Cyclophosfamide as Conditioning Regimen for Acute Myeloid Leucemia: Retrospective Experience (1991–2007) of Two Bone Marrow Transplant Unit

Giuseppe Irrera, Giuseppe Messina, Massimo Martino, Giuseppe Console, Giuseppe Milone, MD, Pasquale Iacopino

Blood (2008) 112 (11): 4453.

https://doi.org/10.1182/blood.V112.11.4453.4453

Published: 2008

NARROW

Haploidentical Stem Cell Transplantation Attenuates the Prognostic Impact of FLT3-ITD in Acute Myeloid Leukemia

Use of Bone Marrow or Peripheral Blood Stem Cell Grafts in Non T Cell Depleted Haploidentical Transplants Using Post-Transplant Cyclophosphamide, an ALWP-EBMT Analysis

Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF

Fast and Non-Invasive Identification of Tumorigenic-Proliferative Biomarker in Myeloproliferative and Lymphoproliferative Disorders

A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy

Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience

Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting

Validation of the Cibmtr Score in Predicting the Outcome of Hematopoietic Stem-Cell Transplantation in AML Patients Not in Complete Remission At the Time of Conditioning: A Retrospective Analysis On Behalf of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Autologous Hematopotoietic Stem Cell Transplantation in Multiple Sclerosis with An Intermediate Intensity Conditioning Regimen: The Italian Multi-Centre Experience

At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study

Is Antifungal Prophylaxis Useful In Stem Cell Transplantation (SCT) During Hospitalization?.

Incidence of Febrile Episode During Stem Cell Mobilization (SCM) After High Dose Ciclophosphamide Chemotherapy (HD-CTX) and G-CSF (filgrastim or lenograstim) Administration in Multiple Myeloma (MM) Patients: II Interim Evaluation

Autologous Stem Cell Transplantation (ASCT) with Busulfan Plus Cyclophosfamide as Conditioning Regimen for Acute Myeloid Leucemia: Retrospective Experience (1991–2007) of Two Bone Marrow Transplant Unit

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only